Olema Pharmaceuticals
Filed with the SEC on · accession 0001193125-26-454403
OLMA filed a 8-K (current report) with the SEC on Nov 10, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Olema Pharmaceuticals filed an 8-K furnishing its financial results for the quarter ended September 30, 2026 via a press release under Item 2.02.
✦ Ask GOAX AI about this filing — what it means for OLMA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for OLMA?
Click hereOLMA filed a 8-K (SEC filing). Olema Pharmaceuticals filed an 8-K furnishing its financial results for the quarter ended September 30, 2026 via a press release under Item 2.02.
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Get alerts when OLMA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days